Clinical trials
Terminated Phase 2 Peripheral Arterial Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Celularity Incorporated | 1 |
| Mercator MedSystems, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| University Hospital, Toulouse | 1 |
| University of California, San Francisco | 1 |
| University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 7 |
| Arterial Occlusive Diseases | 1 |
| Arteriosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Chronic Limb-Threatening Ischemia | 1 |
| Diabetic Foot | 1 |
| Heart Diseases | 1 |
| Insulin Resistance | 1 |
| Intermittent Claudication | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.